Compass Pathways stock took a hit in early June. Lykos Therapeutics just got some extremely bearish news from regulators. Regulators being skeptical about Lykos' medicine could be bad for Compass.

Compass is a market leader in real estate brokerage, showing strong growth and cost control despite a sluggish market. I expect the real estate market to improve as the Federal Reserve is likely to ...

FTSE 100 contract caterer Compass Group (LSE:CPG) absolutely dominates its industry, but the stock’s faltered this year. So should I buy the dip, or is this a sign of things to come? Itâ s fair to say ...